Oura launches Ring 5 with a blood pressure trend feature that skipped FDA review
Oura introduced its Ring 5 on May 28, 2026, with plans to add a feature that tracks overnight blood pressure patterns and tells users when to see a doctor. The feature shows trends rather than systolic and diastolic readings, and it is sold as a wellness tool without FDA review under the agency's January 2026 wellness guidance. Oura said a separate feature to flag possible hypertension is being studied and will go through the FDA. The launch also added health record import and access to clinicians through Counsel Health and ResMed.
Why it's notable: Clinicians should expect patients to bring in blood pressure trends from rings and watches that no regulator has checked for accuracy. Experts quoted by STAT warned that these unvetted blood pressure features are spreading quickly.